Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127234001 | 12723400 | 1 | I | 20160820 | 20160906 | 20160908 | 20160908 | EXP | FR-ROCHE-1827156 | ROCHE | 13.00 | YR | F | Y | 0.00000 | 20160908 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127234001 | 12723400 | 1 | PS | VALIUM | DIAZEPAM | 1 | Oral | U | 13263 | 300 | MG | ||||||||
| 127234001 | 12723400 | 2 | SS | LAROXYL | AMITRIPTYLINE | 1 | Oral | U | 0 | 1.5 | G |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127234001 | 12723400 | 1 | Product used for unknown indication |
| 127234001 | 12723400 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127234001 | 12723400 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127234001 | 12723400 | Coma | |
| 127234001 | 12723400 | Electrocardiogram QRS complex prolonged | |
| 127234001 | 12723400 | Hallucination | |
| 127234001 | 12723400 | Hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127234001 | 12723400 | 1 | 20160820 | 0 | ||
| 127234001 | 12723400 | 2 | 20160820 | 0 |